Heart disease in diabetes mellitus: A challenge for early diagnosis and intervention

Experimental and Clinical Endocrinology and Diabetes

Volumn 106, Issue 1, 1998, Pages 16-24

  Tschoepe, D ^a   Roesen, P ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Cardiopathy; Coronary artery disease; Corposcular hyperreactivity; Diabetes mellitus; Endothelial dysfunction

Indexed keywords

ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; FIBRINOGEN; GLUCOSE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

BLOOD CLOTTING; CARDIOVASCULAR RISK; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; DIABETES MELLITUS; DYSLIPOPROTEINEMIA; EARLY DIAGNOSIS; FIBRINOLYSIS; HEART DISEASE; HEART INFARCTION; HUMAN; HYPERTENSION; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0031884036     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1211944     Document Type: Review

References (115)

1. Abraira C, Colwell J, Nuttwall F, Sawin CT, Henderson W, Comstock JP, Emanuele NV, Levin SR, Pacold I, Lee HS: Cardiovascular events and correlates in the veterans affairs diabetes feasibility trial. Veterans affairs cooperative study on glycemic control and complications in type II diabetes. Arch Intern Med 157: 181-188, 1997
2. Agewall S, Fagerberg B, Attvall S, Ljungman S, Urbanavicius V, Tengborn L, Wikstrand J: Microalbuminuria, insulin sensitivity and haemostatic factors in non-diabetic treated hypertensive men. Risk factor intervention study group. J Intern Med 237: 195-203, 1995
3. Alderman EL for the BARI investigators: Comparison of coronary artery bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 335: 217-225, 1996
4. Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P: The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. New Engl J Med 332: 488-493, 1995
5. Antiplatelet trialist collaboration: Collaborative overview of randomised trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 308: 81-106, 1994
6. Bach R, Jung F, Kohsiek I, Özbek C, Spitzer S, Scheller B, Dyckmanns J, Schieffer H: Factors affecting the restenosis rate after percutaneous transluminal coronary angioplasty. Thromb Res 74 Suppl 1: 55-67, 1994
7. Beckmann S, Schirop T, Bocksch W, Lekutat C, Wissman CV, Schartl M: Beurteilung der linksventrikulären Pumpfunktion mittels Streßechokardiographie als Screening-Methode bei insulinpflichtigen Typ-I- und Typ-II-Diabetikern. Diabetes und Stoffwechsel 6: 93-101, 1997
8. Berger M: Is hyperinsulinaemia a risk factor for atherosclerosis? In: Gries FA, Petersen-Braun M, Tschoepe D, van de Loo J (eds.): Haemostasis and diabetic angiopathy. Pathophysiology and Therapeutic Concepts pp. 9-14, Georg Thieme Verlag Stuttgart-New York, 1993
9. Bonora E, Tesari R, Micciolo R, Zenere M, Targher G, Padovani G, Falezza G, Muggeo M: Intimal-medial thickness of the carotid artery in nondiabetic and NIDDM patients. Diab Care 20: 627-631, 1997
10. Brand FN, Abbott RD, Kannel WB: Diabetes, intermittent claudication, and risk of cardiovascular events. The Framingham Study. Diabetes 38: 504-509, 1989
11. Bransome ED: Financing the care of diabetes mellitus in the U.S. Diab Care 15 Suppl 1: 1-5, 1992
12. Bressler P, Bailey SR, Matsuda M, DeFronzo RA: Insulin resistance and coronary artery disease. Diabetologia 39: 1345-1350, 1996
13. Burchfield CM, Reed DM, Marcus EB, Strong JP, Hayashi T: Association of diabetes mellitus with coronary atherosclerosis and myocardial lesions. An autopsy study from the Honolulu Heart Program. Am J Epidemiol 137: 1328-1340, 1993
14. Cabin HS, Roberts WC: Quantitative comparison of extent of coronary narrowing and size of healed myocardial infarct in 33 necropsy patients with clinically recognized and in 28 with clinically unrecognized ("silent") previous acute myocardial infarction. Am J Cardiol 50: 677-681, 1982
15. Califf RM, Lee KL, Granger CB, Ohman EM: Predictors of outcome of reperfusion therapy. Eur Heart J 18: 728-735, 1997
16. Carter AM, Grant PJ: Vascular homeostasis, adhesion molecules, and macrovascular disease in non-insulin-dependent diabetes mellitus. Diab Med 14: 423-432, 1997
17. Celentano A, Vaccaro O, Tammaro P, Galderisi M, Crivro M, Oliviero M, Imperatore G, Palmieri V, Iovino V, Riccardi G, deDivitiis O: Early abnormalities of cardiac function in non-insulin-dependent diabetes mellitus and impaired glucose tolerance. Am J Cardiol 76: 1173-1176, 1995
18. Chan P, Pan WH: Coagulation activation in type 2 diabetes mellitus: The higher coronary risk of female diabetic patients. Diabetes Med 12: 504-7, 1995
19. Cohen RA: Dysfunction of vascular endothelium in diabetes mellitus. Circulation 87 Suppl 5: 67-76, 1993
20. Colwell JA for the ADA: Consensus statement. Role of cardiovascular risk factors in prevention and treatment of macrovascular disease in diabetes. Diab Care 12: 573-579, 1989.
21. Colwell JA: Antiplatelet drug and prevention of macrovascular disease in diabetes mellitus. Metabolism 41: 7-10, 1992
22. Colwell JA: Vascular thrombosis in type II diabetes mellitus. Diabetes 42: 8-11, 1993
23. Colwell JA: Unanswered research questions about metabolic control in non- insulin- dependent diabetes mellitus. Ann Im Med 1241/2: 178-179, 1996
24. Crall FV, Roberts WC: The extramural and intramural coronary arteries in juvenile diabetes mellitus. Analysis of nine necropsy patients aged 19 to 38 years with onset of diabetes before age 15 years. Am J Med 64: 221-230, 1978
25. DERI Mortality Study Group: International analysis of insuin-dependent diabetes mellitus mortality: A preventable mortality perspective. The diabetes epidemiology research international (DERI) Study. Am J Epidemiol 142: 612-618, 1995
26. Diabetes Epidemiology Research International Mortality Study Group: International evaluation of cause-specific mortality and IDDM. Diabetes Care 14: 55-60, 1991
27. Donahue RP, Abbott RD, Reed DM, Yano K: Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program. Diabetes 36: 689-692, 1987
28. Eastman RC, Keen H: The impact of cardiovascular disease on people with diabetes: the potential for prevention. Lancet 350 Suppl I: 29-32, 1997
29. Faerman I, Faccio E, Milei J, Nunez R, Jadzinsky M, Fox D, Rapaport M: Autonomie neuropathy and painless myocardial infarction in diabetic patients. Histologic evidence of their relationship. Diabetes 26: 1147-1158, 1977
30. Fava S, Azzopardi J, Muscat HA, Fenech FF: Factors that influence outcome in diabetic subjects with myocardial infarction. Diabetes Care 16: 1615-18, 1993
31. Fein FS, Scheurer J: Heart disease in diabetes. In: Ellenberg, Rifkin (eds.) Diabetes mellitus. Theory and practice. 4th ed, pp. 812-823, Elsevier Publishers, 1990
32. Fisher BM, Frier BM: Evidence for a specific heart disease of diabetes in humans. Diab Med 7: 478-489, 1990
33. Fitzgerald DJ, Roy L, Catella F, Fitzgerald GA: Platelet activation in unstable coronary disease. N Engl J Med 315: 983-989, 1986
34. Folsom AJ, Szklo M, Stevens J, Liao F, Smith R, Eckfeldt JH: A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes. Diab Care 20: 935-942, 1997
35. Fontbonne A, Charles MA, Thibult N, Richard JL, Claude JR, Warnet JM, Rosselin GE, Eschwège, E: Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: The Paris prospective study, 15-year follow-up. Diabetologia 34: 356-361, 1991
36. Frade LJG, de la Calle H, Alava I, Navarro JL, Creighton LJ, Gaffney PJ: Diabetes mellitus as a hypercoagulable state: Its relationship with fibrin fragments and vascular damage. Thromb Res 47: 533-540, 1987
37. Fuster V, Badimon L, Badimon JJ, Chesebro JH: The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 326: 242-250, 1992
38. Genest J Jr, Cohn JS: AIMTI: Clustering of cardiovascular risk factors: targeting high-risk individuals. Am J Cardiol 76: 8A-20A, 1995
39. Genuth S: Exogenous insulin administartion and cardiovascular risk in non-insulin-dependent and insulin-dependent Diabetes Mellitus. Ann Intern Med 124: 104-109, 1996
40. Geroulakos G, O'Gorman DJ, Kalodiki E, Sheridan DJ, Nicolaides AN: The carotid intima-media thickness as a marker of the presence of severe symptomatic coronary artery disease. Eur Heart J 15: 781-785, 1994a
41. Geroulakos G, Ramaswami G, Veller MG, Fisher GM, Renton S, Nicolaides A, Waldorn HA, Diamond J, Elkeles RS: Arterial wall changes in type 2 diabetic subjects. Diab Med 11: 692-695, 1994b
42. Gerstein H, Yusuf S: Dysglycaemia and risk of cardiovascular disease. The Lancet 347: 949-950, 1996
43. Gray RP, Yudkin JS, Patterson DL: Enzymatic evidence of impaired reperfusion in diabetic patients after thrombolytic therapy for acute myocardial infarction: A role for plasminogen activator inhibitor? Br Heart J 70: 530-536, 1993
44. Gries FA, Petersen Braun M, Tschoepe D, van de Loo J: Haemostasis and diabetic angiopathy. Pathophysiology and therapeutic concepts. Georg Thieme Verlag, Stuttgart-New York, 1993
45. Grossman E, Rosenthal T: Hypertensive heart disease and the diabetic patient. Curr Op Cardiol 10: 458-465, 1995
46. Haffner S: Management of dyslipidemia in diabetic subjects: ADA Technical Review, (in press)
47. Hanefeld M, Fischer S, Julius U, Schulze J, Schwanebeck U, Schmechel H, Ziegelasch HJ, Lindner for the DIS Group: Risk factors for myocardial infarction and death in newly detected NIDDM: The diabetes intervention study, 11-year follow-up. Diabetologia 39: 1577-1583, 1996
48. Harris MI: Undiagnosed NIDDM: Clinical and public health Issues. Diab Care 16: 642-652, 1993
49. Hasenfuss G: Cardiac changes in diabetes. Exp Clin Endocrinol 103: 352-353, 1995
50. Herlitz J, Wognsen GB, Emanuelsson H, Haglid M, Karlson BW, Karlsson T, Albertson P, Westberg S: Mortality and morbidity in diabetic and nondiabetic patients during a 2-year period after coronary artery bypass grafting. Diab Care 19: 698-7703, 1996
51. Hjalmarson A, Gilpin EA, Nicod P, Dittrich H, Henning H, Engler R, Blacky R, Smith S, Ricou F, Ross J Jr: Differing circadian patterns of symptom onset in subgroups of patients with acute myocardial infarction. Circulation 80: 267-275, 1989
52. Iwasaka T, Takahashi N, Nakamura S, Sugiura T, Tarumi N, Kimura Y, Okubo N, Taniguchi H, Matsui Y, Inada M: Residual left ventricular pump function after acute myocardial infarction in NIDDM patients. Diab Care 15: 1522-1526, 1992
53. Jacobs J, Sena M, Fox N: The cost of hospitalization for the late complications of diabetes in the United States. Diab Med 8: 523-529, 1990
54. Jacoby RM, Nesto RW: Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and prognosis. J Am Coll Cardiol 20: 736-44, 1992
55. Job FP, Wolfertz J, Meyer R, Hübinger A, Gries FA, Kuhn H: Hyperinsulinism in patients with coronary artery disease. Cor Art Dis 5: 487-482, 1994
56. Jonas M, Reicher-Weis H, Boyko V, Shotan A, Mandelzweig L, Goldbourt U, Behar S for the Bezafibrate Infarction (BIP) Study Group: Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease. Am J Cardiol 77: 1273-1277, 1996
57. Julien J: Cardiac complications in non-insulin-dependent diabetes mellitus. J Diabetes Complications 11: 123-130, 1997
58. Kannel WB, Hjortland M, Castelli WP: Role of diabetes in congestive heart failure: The Framingham study. Am J Cardiol 34: 29-34, 1974
59. Kip KE, Faxon DP, Detre KM, Yen W, Kelsey SF, Currier JW for the Investigators of the NHLBI PTCA Registry: Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 94: 1818-1825, 1994
60. Kjekshus J, Gilpin E, Cali G, Blackey AR, Henning H, Ross J Jr: Diabetic patients and beta-blockers after acute myocardial infarction. Eur Heart J 11: 43-50, 1990
61. Kleiger RE, Miller P, Bigger T, Moss AJ, and the Multicenter Post-Infarction Research Group: Decreased heart Rate Variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 59: 256-262, 1987
62. Knobl P, Schernthaner G, Schnack C, Pietschmann P, Proidl S, Prager R, Vukovich T: Haemostatic abnormalities persist despite glycaemic improvement by insulin therapy in lean type 2 diabetic patients. Thromb Haemost 73: 165-6, 1995.
63. Koivisto VA, Stevens LK, Mattock M, Ebeling P, Muggeo M, Stephenson J, Idzior-Walus B for the EURODIAB IDDM Complications Study Group: Cardiovascular disease and its risk factors in IDDM in Europe. Diab Care 19: 689-697, 1996
64. Kuller LH: Magnitude of the problem. In: Proceedings of the National Heart, Lung, and Blood Institute. Symposium on rapid identification and treatment of acute myocardial infarction. Issues and answers. NIH Publication No. 91-3035: 3-24, 1991
65. Laakso M: Glycemic control and the risk for coronary heart disease in patients with non-insulin-dependent diabetes mellitus. The Finnish studies. Ann Int Med 1241/2: 127-130, 1996
66. Lefkovits J, Plow E, Topol EJ. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med 323: 1553-1559, 1995
67. Lehmann ED, Riley WA, Clarkson P, Gosling RG: Non-invasive assessment of cardiovascular disease in diabetes mellitus. Lancet 350 Suppl I: 14-20, 1997
68. Löwel H, Dinkel R, Hörmann A, Stieber J, Görther E: Herzinfarkt und Diabetes. Ergebnisse der Augsburger Herzinfarkt-Follow-Up Studie 1985 bis 1990, in Janka HU (ed.): Diabetes Epidemiologie in Deutschland. Diabetes und Stoffwechsel 5, Suppl 19-23, 1996
69. Mäki M, Nuutila P, Laine H, Voipio-Pulkki LM, Haaparanta M, Solin O, Knuuti J: Myocardial glucose uptake in patients with NIDDM and stable coronary artery disease. Diabetes 46: 1491-1496, 1997
70. Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenström A, Wedel H, Welin L on behalf of the DIGAMI study group: Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI Study): Effects on mortality at 1 year. JACC 26: 57-65, 1995
71. Malmberg K, Ryden L, Hamsten A, Herlitz J, Waldenström A, Wedel H on behalf of the DIGAMI study group: Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. Eur Heart J 17: 1337-1344, 1996
72. Meigs JB, Singer DE, Sullivan LM, Dukes KA, D'Agostino RB, Nathan DM: Metabolic control and prevalent cardiovascular disease in non-insulin-dependent diabetes mellitus (NIDDM): The NIDDM patient outcome research team. Am J Med 102: 38-47, 1997
73. Mizuno K, Satomura K, Miyamoto A, Arakawa K, Shibuya T, Arai T, Kurita A, Nakamura H, Ambrose JA: Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes. N Engl J Med 326: 287-291, 1992
74. Nathan DM, Meigs J, Singer E: The epidemiology of cardiovascular disease in type 2 diabetes mellitus: How sweet it is ... or is it? Lancet 350 Suppl I: 4-9, 1997
75. Niakan E, Harati Y, Rolak LA, Comstock JP, Rokey R: Silent myocardial infarction and diabetic cardiovascular autonomie neuropathy. Arch Intern Med 146: 2229-2230, 1986
76. Nitenberg A, Valensi P, Sachs R, Dali M, Aptecar E, Attali JR: Impairment of coronary vascular reserve and Ach-induced coronary vasodilation in diabetic patients with angiografically normal coronary arteries and normal left ventricular systolic function. Diabetes 42: 1017-1025, 1993
77. Nuutila P, Knuuti J, Ruotsalainen U, Koivisto VA, Eronen E, Teräs M, Bergman J, Haaparanta M, Voipi-Pulkki LM, Viikari J, Rönnemaa T, Wegelius U, Yki-Järvinen H: Insulin resistance is localized to skeletal but not heart muscle in type 1 diabetes. Am J Physiol 264 (Endocrinol Metab 27): E756-E762, 1993
78. Packer L, Roesen P (eds.): Oxidativer Streß als Ursache des kardialen Risikos bei Diabetes? Diabetes und Stoffwechsel 6, Suppl 2, 1997
79. Paillole C, Ruiz J, Juliard JM, Leblanc H, Gourgon R, Passa Ph: Detection of coronary artery disease in diabetic patients. Diabetologia 38: 726-731, 1995
80. Panzram G: Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 30: 123-131, 1987
81. Patrono C, Davi G: Antiplatelet agents in the prevention of diabetic vascular complications. Diab Metab Rev 9: 177-188, 1993
82. Prospective Diabetes Study Group: Perspectives in diabetes. U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: A progressive disease. Diabetes 44: 1249-1258, 1995
83. Pyörälä K, Pedersen TR, Kjekshus J, Olsson AG, Thorgeirsson G for the Scandinavian Simvastatin Survival Study (4S) Group: Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian simvastatin survival study (4S). Diabetes Care 20: 614-620, 1997
84. Quigley PJ, Hlatky MA, Hinohara T, Rendall DS, Perez JA, Phillips HR, Califf RM, Stack RS: Repeat percutaneous transluminal coronary angioplasty and predictors of recurrent restenosis. Am J Cardiol 63: 409-413, 1989
85. Rabbani LE, Edelman ER, Ganz P, Selwyn AP, Loscalzo J, Bittl JA: Relation of restenosis after excimer laser angioplasty to fasting insulin levels. Am J Cardiol 73: 323-327, 1994
86. Ranjadayalan K, Umachandran V, Ambepityia G, Kopelman PG, Mills PG, Timmis AD: Prolonged anginal perceptual threshold in diabetes: Effects on exercise capacity and myocardial ischemia. JACC 16: 1120-1124, 1990
87. Rosen P, Pogatsa G, Tschöpe D, Addicks K, Reinauer H: Diabetic cardiopathy-pathophysiological concepts and therapeutic approaches. Klin.Wochenschr. 69 Suppl XXIX: 3-15, 1992
88. Savage JP: Cardiovascular complications of diabetes mellitus: What we know and what we need to know about their prevention. Ann Int Med 124: 123-126, 1996
89. Scala C, LaPorte RE, Dorman JS, Songer TJ, Orchard T, Kuller LH, Becker D, Drash AL: Insulin-dependent diabetes mellitus mortality. The risk of cigarette smoking. Circulation 82: 37-43, 1990
90. Schiffrin EL, Intengan HD, Thibault G, Touyz RM: Clinical significance of endothelin in cardiovascular disease. Curr Op Cardiol 12: 354-367, 1997
91. Silva JA, Escobar A, Collins TJ, Ramee SR, White CJ: Unstable Angina. A comparison of angioscopic findings between diabetic and nondiabetic patients. Circulation 92: 1731-1736, 1995
92. Singer DE, Moulton AW, nathan DM: Diabetic myocardial infarction. Interaction of diabetes with other preinfarction risk factors. Diabetes 38: 350-356, 1989
93. Singer DE, Nathan DM, Anderson KM, Wilson PWF, Evans JC: Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham heart study. Diabetes 41: 202-208, 1992
94. Songer TJ, DeBerry K, LaPorte RE, Tuomilehto J: International comparisons of IDDM mortality. Diab Care 15 Suppl 1: 15-21, 1992
95. Sprafka JM, Burke GL, Folsom AR, McGovern PG, Hahn LP: Trends in prevalence of diabetes mellitus in patients with myocardial infarction and effect of diabetes on survival. The Minnesota heart survey, Diab Care 14: 537-543, 1991
96. Standl E, Balletshofer B, Dahl B, Weichenhain B, Stiegler H, Hörmann A, Holle R: Predictors of 10-year macrovascular and overall mortality in patients with NIDDM. The Munich general practitioner project. Diabetologia 39: 1540-1545, 1996
97. Stein B, Weintraub WS, Gebhart SSP, Cohen- Bernstaein CL, Grosswald R, Liberman HA, Douglas JS, Morris DC, King SB: Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation 91: 979-989, 1995
98. Stroedter D, Overbeck A, Syed AS, Seitz S, Bretzel RG, Federlin K: Improvement of cardiac performance and metabolism in long-tern diabetes mellitus afer treatment with insulin. Exp Clin Endocrinol 103: 354-360, 1995
99. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 329: 977-986, 1993
100. The EPIC Investigators: Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. Lancet 343: 881-886, 1994a
101. The EPIC Investigators: Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 330: 956-961, 1994b
102. Titus B, Sherman T: Asymptomatic myocardial ischemia during percutaneous transluminal coronary angioplasty and importance of prior Q-wave infarction and diabetes mellitus. Am J Cardiol 68: 735-739, 1991
103. Tschöpe D, Rosen P: Gerinnungsstörungen bei metabolischem Syndrom und Typ-II-Diabetes. In: Mehnert H (ed.) Herz, Gefäße und Diabetes, pp. 117-132, Medikon Verlag, München, 1997
104. Tschöpe D, Rösen P, Schwippert B, Gries FA: Platelets in diabetes: The role in the hemostatic regulation in athero-sclerosis. Sem Thromb Hemostas 19: 122-128, 1993
105. Tschoepe D, Schwippert B, Gries FA: Platelet fibrinogen receptor blockers (GPIIbIIIa-antagom'sts) are equally effective in IDDM. Diabetes 46, Suppl 1: 117A, 1997
106. Uusitupa MIJ, Niskanen LK, Siitonen O, Voutilainen E, Pyorälä K: Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in Type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 36: 1175-1184, 1993
107. Valsania P, Zarich SW, Kowalchuk GJ, Kosisinski E, Warram JH, Krolewski AS: Severity of coronary artery disease in young patients with insulin-dependent diabtes mellitus. Am Heart J 122: 695-700, 1991
108. Vavuranakis M, Stefanidis C, Toutouzas K, Pitsavos C, Spanos V, Toutouzas P: Impaired compensatory coronary artery enlargement in atherossclerosis contributes to the development of coronary artery stenosis in diabetic patients. Eur Heart J 18: 1090-1094, 1997
109. Waller BF, Palumbo PJ, Lie JT, Roberts WC: Status of the coronary arteries at necropsy in diabetes mellitus with onset after age 30 years. Analysis of 229 diabetic patients with and without clinical evidence of coronary heart disease and comparison to 183 control subjects. Am J Med 69: 498-506, 1980
110. Yamasaki Y, Kawamori Y, Matsushima H, Nishizawa H, Kodama M, Kajimoto Y, Morishima T, Kamada T: Atherosclerosis in carotid artery of young IDDM patients monitored by ultrasound high-resolution B-mode imaging. Diabetes 43: 634-639, 1994
111. Yudkin J: How can we best prolong life? Benefits of coronary risk factor reduction in non-diabetic and diabetic subjects. BMJ 306: 1313-1318, 1993
112. Zarich S, Waxmann S, Freeman RT, Mittleman M, Hegarty P, Nesto RW: Effect of autonomie nervous system dysfunction on the circadian pattern of myocardial ischemia in Diabetes Mellitus. JACC 24: 956-962, 1994
113. Ziegler D: Diabetic Cardiovascular autonomic neuropathy: Prognosis, diagnosis and treatment. Diab Metab Rev 10: 339-383, 1994
114. Zimmet PZ, Alberti KGMM: The changing faces of macrovascular disease in non-insulin-dependent diabetes mellitus: an epidemic in progress. Lancet 350: Suppl 1-4, 1997
115. Zola B, Kahn JK, Juni JE, Vinik AI: Abnormal cardiac function in diabetic patients with autonomie neuropathy in the absence of ischemic heart disease. J Clin Endocrinol Metab 63: 208-214, 1986